Retrospective observational analysis of the use of an architecturally unique dermal regeneration template (Derma Pure®) for the treatment of hard‐to‐heal wounds
Authors:
Open Access
- 13 September 2016
- journal article
- research article
- Published by Wiley in International Wound Journal
- Vol. 14 (4) , 666-672
Abstract
The purpose of this analysis was to evaluate the use of DermaPure, a decellularised human skin allograft, in the treatment of a variety of challenging wounds. This retrospective observational analysis reviewed a total of 37 patients from 29 different wound clinics across the USA. Each patient received one application of DermaPure which was followed until complete closure. A statistical analysis was performed with the end point being complete healing. All wounds on average, had a duration of 56 weeks and healed in an average time of 10·58 weeks. Individual wound categories included diabetic foot ulcers, which healed in 8·21 weeks; venous leg ulcers, which healed in 11·29 weeks; and surgical/traumatic wounds, which healed in 11·8 weeks.Keywords
Funding Information
- Tissue Regenix US
This publication has 29 references indexed in Scilit:
- Evidence-based management of common chronic lower extremity ulcersDermatologic Therapy, 2013
- The role of skin substitutes in the management of chronic cutaneous woundsWound Repair and Regeneration, 2013
- Evaluation of Host Tissue Integration, Revascularization, and Cellular Infiltration Within Various Dermal SubstratesAnnals of Plastic Surgery, 2012
- Dynamic reciprocity in the wound microenvironmentWound Repair and Regeneration, 2011
- A Retrospective Clinical Study of 188 Consecutive Patients to Examine the Effectiveness of a Biologically Active Cryopreserved Human Skin Allograft (TheraSkin ®) on the Treatment of Diabetic Foot Ulcers and Venous Leg UlcersFoot & Ankle Specialist, 2010
- Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre studyInternational Wound Journal, 2009
- Apligraf in the Treatment of Neuropathic Diabetic Foot UlcersThe International Journal of Lower Extremity Wounds, 2009
- A Multicenter Study Involving the Use of a Human Acellular Dermal Regenerative Tissue Matrix for the Treatment of Diabetic Lower Extremity WoundsAdvances in Skin & Wound Care, 2008
- The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16‐week pilot studyInternational Wound Journal, 2006
- Outcomes of allogenic acellular matrix therapy in treatment of diabetic foot wounds: an initial experienceInternational Wound Journal, 2005